Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Yu

Showing results (961-970 of 970) with videos related to

Pageof 97
Sort By:
You have reached the last page of results.This site can display upto 970 results.
Molecular Pharmaceutics|July 25, 2018
Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug ConjugatesZhonghua Pei, Chunjiao Chen, Jinhua Chen, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
American Journal of Hematology|January 3, 2023
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib studyElisabeth A Lasater, Dhara N Amin, Rajat Bannerji, et al.
Chemical Science|April 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptidesNeelie Zacharias, Vladimir N Podust, Kimberly K Kajihara, et al.
Bioconjugate Chemistry|April 11, 2019
Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In VivoDian Su, Jinhua Chen, Ely Cosino, et al.
Journal of Medicinal Chemistry|May 18, 2026
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft ModelsSummer A Baker Dockrey, Pravin Chandra, Huifen Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2025
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory StudyFeng-Qi Liu, Zhuo-Yu An, Li-Juan Cui, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Journal of Neonatal-Perinatal Medicine|April 18, 2022
Proceedings of the 13th International Newborn Brain Conference: Other forms of brain monitoring, such as NIRS, fMRI, biochemicalEkaterina Balashova, Olivia Beaulieu, Imen Benhmida, et al.
Redox Biology|June 22, 2024
Ferroptosis in health and diseaseCarsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Pageof 97

Showing results (961-970 of 970) with videos related to

Sort By:
Pageof 97
You have reached the last page of results.This site can display upto 970 results.
Molecular Pharmaceutics|July 25, 2018
Exploration of Pyrrolobenzodiazepine (PBD)-Dimers Containing Disulfide-Based Prodrugs as Payloads for Antibody-Drug ConjugatesZhonghua Pei, Chunjiao Chen, Jinhua Chen, et al.
Journal of Medicinal Chemistry|February 17, 2021
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S Dragovich, Thomas H Pillow, Robert A Blake, et al.
American Journal of Hematology|January 3, 2023
Targeting MCL-1 and BCL-2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non-Hodgkin lymphoma: Results from preclinical models and a Phase Ib studyElisabeth A Lasater, Dhara N Amin, Rajat Bannerji, et al.
Chemical Science|April 13, 2022
A homogeneous high-DAR antibody-drug conjugate platform combining THIOMAB antibodies and XTEN polypeptidesNeelie Zacharias, Vladimir N Podust, Kimberly K Kajihara, et al.
Bioconjugate Chemistry|April 11, 2019
Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In VivoDian Su, Jinhua Chen, Ely Cosino, et al.
Journal of Medicinal Chemistry|May 18, 2026
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft ModelsSummer A Baker Dockrey, Pravin Chandra, Huifen Chen, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 5, 2025
Correlation Between Fecal Microbiota and Corticosteroid Responsiveness in Primary Immune Thrombocytopenia: an Exploratory StudyFeng-Qi Liu, Zhuo-Yu An, Li-Juan Cui, et al.
Muscle & Nerve|October 16, 2020
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosisSabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, et al.
Journal of Neonatal-Perinatal Medicine|April 18, 2022
Proceedings of the 13th International Newborn Brain Conference: Other forms of brain monitoring, such as NIRS, fMRI, biochemicalEkaterina Balashova, Olivia Beaulieu, Imen Benhmida, et al.
Redox Biology|June 22, 2024
Ferroptosis in health and diseaseCarsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Pageof 97